Delivery Order SPE2DB20D7059-SPE2DB25FGRL3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,185.96 to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, an oral antibiotic commonly used to treat bacterial infections across military and federal healthcare systems. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $1,246.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, an oral antibiotic commonly used to treat bacterial infections. The award was issued on December 12, 2025, with an ultimate completion date of December 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without any set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,733.84 to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, an oral antibiotic commonly prescribed for bacterial infections. The contract, awarded April 30, 2025, with completion by May 1, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $6,555.75 to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, a commonly prescribed oral antibiotic. The contract is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 2, 2025. No set-aside designation was used for this competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,939.11 to AmerisourceBergen Drug Corp for the supply of Cefdinir 300 mg capsules (60-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Cefdinir is a third-generation cephalosporin antibiotic commonly used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) valued at $2,840.50. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award practices. The order is set to be completed by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cefdinir is a third-generation cephalosporin...
- The Defense Logistics Agency awarded a $2,331.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cefdinir 300 mg capsules (60-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefdinir 300 mg capsules (60-count units) under a firm fixed price contract valued at $2,574.49. The award, made on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a contract ceiling value of $1,774.40. This firm fixed price delivery order, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) under a firm fixed-price contract with a ceiling value of $1,141.79. This non-set-aside award represents a competitive delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The ultimate completion...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRL3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, a broad-spectrum antibiotic commonly used for bacterial infections in military and veteran healthcare settings. This $1,103.02 firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. This delivery order represents a small-value transaction under AmerisourceBergen Drug Corp's substantially larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's consistent receipt of competitively awarded federal contracts demonstrates its established capability to meet rigorous federal procurement standards and serve as a reliable source for critical pharmaceutical supplies to military and government healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/11/25 |